Industry collaboration
Cancer Research KI strives to serve as a link facilitating interaction between Pharmaceutical companies and the cancer researchers at KI, with the aim of succesful longlasting collaborations.
In order for research findings to benefit society and patients there is a need for succesfull collaboration between the university, health care sector and industry. Cancer Research KI seeks to facilitate and promote collaboration with researchers in the cancer area at KI, and interacts with several Pharma companies. We are always open for new initiatives and encourage researchers with potentially interesting projects, as well as Pharma companies interested to collaborate, to get in touch for discussion.
Photo: N/AIndustry-academia collaborations, seminar series by Cancer Reseach KI
Welcome to the seminar organised by Cancer Research KI and LIF (The Swedish Association of the Pharmaceutical Industry).
Date and time: 4th of December 2024, 15:00-17:00 followed by AW
Title: Biomarker-driven precision medicine
Venue: Ragnar Granit, Biomedcium, Solna Campus
Registration required
Merck-KI Science Day 2019
Karolinska Institutet and Merck KGaA, Germany, currently run several joint projects in the fields of oncology, immuno-oncology and immunology. The current oncology/ immuno-oncology projects are headed at KI by Randall Johnson, Urban Lendahl and Evren Alici.
A first Merck-KI Science Day took place at the Merck headquarters in Darmstadt Feb. 12th, 2019 to strengthen the current collaboration and allow for discussion regarding new joint projects.
KI-Roche WS 2015
KI and Roche had an active Master Collaborative Agreement (MCA) for strategic collaboration in the Cancer Research field (signed by KI and Roche global research organization in December 2014) during 2015-17. The aim of the agreement was to develop new and better therapies and more specific methods for analyses, as well as to identify novel signal pathways as potential drug targets. The MCA was featured in a news article in LIFe-time.se.
A joint KI-Roche workshop in Oncology was held at Nobel Forum KI Solna October 19-20, 2015 with the ambition to allow interaction and discussion regarding possibilities for joint research projects.
The Joint Steering Committee (JSC)* met regularly during the agreement period. It was jointly agreed not to prolongue the MCA, but to continue a dialogue and interaction around potentielly interesting collaborative projects.
* JSC Members: Astrid Kiermaier (Roche), Pavel Pisa (Roche), Rune Toftgård (KI), Klas Wiman (KI), Chair: Gabriele Beer (Roche). Alliance Directors: Björn Arvidsson (Roche) and Sandra Falck (KI).